Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 6/20 | 0.37 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.31 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.31 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1274727 | 0.89 | CA1 (0.41) | TSHRCYP3A4NFKB1NPSR1CA1 | |
| SCHEMBL5149659 | 0.87 | CA1 (0.39) | TSHRCYP3A4NFKB1NPSR1CA1 | |
| SCHEMBL829311 | 0.86 | CYP3A4 (0.39) | TSHRCYP3A4NFKB1NPSR1CA1 | |
| SCHEMBL1230499 | 0.84 | CA1 (0.37) | CA1CA2CA4 | |
| SCHEMBL8959411 | 0.84 | CA1 (0.41) | TSHRCYP3A4NFKB1NPSR1CA1 | |
| SCHEMBL8055981 | 0.84 | CA1 (0.41) | TSHRCYP3A4NFKB1NPSR1CA1 | |
| SCHEMBL208042 | 0.84 | CA1 (0.41) | TSHRCYP3A4NFKB1NPSR1CA1 | |
| SCHEMBL7716512 | 0.84 | CA1 (0.41) | TSHRCYP3A4NFKB1NPSR1CA1 | |
| SCHEMBL11500943 | 0.84 | CA1 (0.41) | TSHRCYP3A4NFKB1NPSR1CA1 | |
| SCHEMBL7631487 | 0.84 | CA1 (0.41) | TSHRCYP3A4NFKB1NPSR1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1749859-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2019-09-11 | — | — | EP | disclosed |
| US-20070287780-A1 | Curable Composition | KANEKA CORPORATION (JP) | 2007-12-13 | — | — | US | disclosed |
| EP-1749859-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2007-02-07 | — | — | EP | disclosed |